Research shows race is a factor in disparities of symptom prevalence and response to treatment in multiple sclerosis treatment

Black and Hispanic patients develop more disabilities from multiple sclerosis (MS) and respond to treatments for the disease differently compared to white patients who also have the disease, according to recent findings by researchers at The University of Texas Health Science Center at Houston (UTHealth) at the Americans Committee for Treatment and Research in Multiple Sclerosis Forum 2021.